Table IV.
RBM47 expression in patients with NSCLC from the Xuanwei area.
| RBM47 expression | ||||
|---|---|---|---|---|
| Variables | Patient, n | Negative expression, n (%) | Positive expression, n (%) | P-valuea |
| Tissue | <0.001 | |||
| Normal lung tissues | 72 | 58 (80.6) | 14 (19.4) | |
| Primary tumors of NSCLC | 72 | 12 (16.7) | 60 (83.3) | |
| Sex | 0.329 | |||
| Male | 42 | 7 (16.7) | 35 (83.3) | |
| Female | 30 | 5 (16.7) | 25 (83.3) | |
| Age, years | 0.385 | |||
| <60 | 55 | 8 (14.5) | 47 (85.5) | |
| ≥60 | 17 | 4 (23.5) | 13 (76.5) | |
| Pathological type | 0.007 | |||
| Adenocarcinoma | 73 | 8 (11.0) | 65 (89.0) | |
| Squamous carcinoma | 9 | 4 (44.4) | 5 (55.6) | |
| Tumor size (pT stage) | 0.296 | |||
| T1 | 44 | 9 (20.5) | 35 (79.5) | |
| T2 | 19 | 1 (5.3) | 18 (94.7) | |
| T3/T4 | 9 | 2 (22.2) | 7 (77.8) | |
| Lymph node metastasis (pN stage) | 0.814 | |||
| Negative | 52 | 9 (17.3) | 43 (82.7) | |
| Positive | 20 | 3 (15.0) | 17 (85.0) | |
| AJCC stage at diagnosis | 0.720 | |||
| I | 45 | 9 (20.0) | 67 (80.0) | |
| II | 12 | 2 (16.7) | 10 (83.3) | |
| III | 15 | 1 (6.7) | 14 (93.3) | |
a
According to the χ2 test. RBM47, RNA-binding motif protein 47; NSCLC, non-small cell lung cancer; pT, pathological tumor size; pN, pathological lymph node stage; AJCC, American Joint Committee on Cancer.